Philips_logo_logotype_emblem-700x128.png
Philips delivers Q1 sales of EUR 3.8 billion, with 9% comparable sales growth; net income amounts to EUR 40 million and Adjusted EBITA margin improves 390 basis points to 9.5%
26 avr. 2021 01h00 HE | Royal Philips
April 26, 2021First-quarter highlights Following the agreement to sell the Domestic Appliances business to global investment firm Hillhouse Capital, this business is reported as a discontinued...
Five-year patient-level meta-analysis of ILLUMENATE EU RCT and Pivotal study results confirms safety profile of Philips Stellarex .035” low-dose Drug-Coated Balloon
20 avr. 2021 11h25 HE | Royal Philips
April 20, 2021 Stellarex is the only Drug-Coated Balloon (DCB) to consistently demonstrate no difference in mortality every year through five years when compared with percutaneous transluminal...
Philips produces one hundred millionth blade for its OneBlade, the product that disrupted the grooming market
20 avr. 2021 04h00 HE | Royal Philips
April 20, 2021 Since its launch in 2016, the Philips OneBlade has disrupted grooming markets worldwide, creating a new category - a single tool for shaving, trimming and edgingOneBlade Face + Body...
Philips installs leading digital imaging solutions at new Central Acute Services Building of Westmead Hospital in Sydney Australia
19 avr. 2021 04h00 HE | Royal Philips
April 19, 2021 New state-of-the-art Central Acute Services Building at Westmead Hospital features next-generation diagnostic and neurovascular imaging solutions, aimed at improving the efficiency...
Philips showcases impact of tele-ultrasound advancing Precision Diagnosis at AIUM virtual event
09 avr. 2021 09h00 HE | Royal Philips
April 9, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its participation in the upcoming Annual Integrative...
Philips and Ibex Medical Analytics team to accelerate adoption of AI-powered digital pathology
08 avr. 2021 09h00 HE | Royal Philips
April 8, 2021 Philips and Ibex Medical Analytics cooperate to globally commercialize clinically proven, AI-powered digital pathology solutions Combination of Philips’ digital pathology...
Philips SmartCT 3D image acquisition, visualization and measurement software for its Azurion Image Guided Therapy System receives FDA 510(k) clearance
06 avr. 2021 09h00 HE | Royal Philips
April 6, 2021 Intuitive, table-side touchscreen control offers interventionalists enhanced diagnostic confidence and streamlined workflows [1]Full control of image acquisition and analysis from...
Philips and NHS implement the first regional data integration hub for UK’s National COVID-19 Chest Imaging Database
31 mars 2021 04h00 HE | Royal Philips
March 31, 2021 Cheshire and Merseyside consortium (NHS) is the first region to have achieved this milestone for the UK’s National COVID-19 Chest Imaging Database (NCCID)The deployment of a...
Philips receives high score for its ESG practices from S&P Global Ratings
30 mars 2021 08h00 HE | Royal Philips
March 30, 2021   Philips received a score of 90 out of 100, the highest that S&P Global Ratings has awarded to date Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global...
Philips_logo_logotype_emblem-700x128.png
Philips partners with Orbita to develop conversational voice and chatbot applications to complement its telehealth solutions
29 mars 2021 09h00 HE | Royal Philips
March 29, 2021 Partnership to create AI-based virtual assistants with the human touch needed for effective remote patient engagement Amsterdam, the Netherlands and Boston, U.S. – Royal...